Similarly, when HCC patients were compared with LC patients, the AUC for THIOREDOXIN was also larger than that for AFP (0.874, 0.843–0.901 vs. 0.824, 0.801–0.853, P = 0.004). The gene discussed is AFP; the disease is laryngotracheoesophageal cleft.